Evenflo Company, Inc.

The Evenflo docket, centered on allegations that a line of child booster seats was marketed as safe for children as light as 30 pounds and tested for side-impact protection in a way that did not reflect real-world crash conditions, has held a small and stable pending-action count of 28 since centralization in 2020. This is fundamentally a marketing and sales-practices dispute — plaintiffs allege they paid a premium or relied on safety representations that overstated the product's protective performance — rather than a docket built around confirmed personal-injury outcomes from product failure.

For a funder, that framing matters for how a claim in this docket should be evaluated: the core damages theory is economic (price premium, benefit-of-the-bargain, or consumer-protection statutory damages tied to the marketing claims) rather than bodily-injury damages tied to a specific incident. That places this docket closer to a commercial consumer-protection dispute than to a mass personal-injury tort, even though it is categorized as a products-liability docket.

Given the modest and stable scale of this litigation, funding interest here is more likely to involve a specific plaintiff group's economic-loss claim or a coordinated set of consumer claims than a large personal-injury portfolio, and medical-lien considerations are not a relevant factor for the core marketing-claims theory driving this docket.

Single-matter or small-portfolio commercial litigation finance, sized to the specific consumer-claims theory and damages model at issue, is the appropriate structure here rather than a mass-tort-scale facility. Duration risk in this kind of docket is also worth underwriting on its own terms — consumer-protection and marketing-practices litigation can move through class-certification-adjacent motion practice on a different timeline than an injury-driven tort, and a funder should build that procedural rhythm into any advance rather than assume it will track a typical mass-tort settlement calendar. Criterica Capital's commercial litigation finance line fits this claim type.

Criterica Intelligence's structural brief covers the marketing-claims theory driving this docket in more detail.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.